T1	Participants 65 88	cancer-related fatigue:
T2	Participants 289 312	cancer-related fatigue.
T3	Participants 363 390	Eligible adults with cancer
T4	Participants 748 803	Two hundred ninety patients were accrued to this trial.
T5	Participants 1629 1652	cancer-related fatigue.
